AVX-470

DB18455InvestigationalProtein Based Therapies

AVX-470 is an anti-tumor necrosis factor (TNF) polyclonal antibody (bovine).

Mechanism: Pharmacologically active on Tumor necrosis factor
Curator reviewed
Code names: AVX-470

Resolves to

Targets

What you can answer from here — as of July 09, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with AVX-470, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.